Search

Search Constraints

You searched for: Author/Creator Duricova, Dana

Search Results

2. Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study. Issue 10 (30th November 2021)

3. Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients. (31st March 2022)

4. Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study. Issue 1 (January 2015)

5. Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study. (August 2021)

6. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation. (1st February 2016)

7. Disease course of inflammatory bowel disease unclassified in a European population‐based inception cohort: An Epi‐IBD study. Issue 6 (21st January 2019)

8. DUAL BIOLOGICAL OR SMALL MOLECULE TREATMENT IN INFLAMMATORY BOWEL DISEASES: DATA FROM CLINICAL PRACTICE. (22nd January 2022)

10. EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS – SINGLE CENTRE EXPERIENCE. (26th January 2023)